HOYA Corporation (HOCPY) Stock Analysis & Winston Score
HOYA Corporation is a Japanese company that makes two main types of products: medical devices and advanced optical components. On the medical side, it produces eyeglass lenses, contact lenses, and endoscopes used by doctors to look inside the human body. On the technology side, it makes glass substrates for hard disk drives and photomasks used in semiconductor manufacturing. HOYA is one of the world's largest eyeglass lens makers and a dominant supplier of mask blanks for chipmaking. The company earns revenue by selling these specialized products to hospitals, optical retailers, and electronics manufacturers worldwide. With a market cap around $49 billion and gross margins near 79%, HOYA benefits from strong pricing power in niche markets where precision manufacturing creates high barriers to entry. Its life care segment (lenses and medical devices) provides steady demand, while its information technology segment is tied to semiconductor and data storage cycles. Growth depends on aging populations driving demand for vision care and endoscopy, though slowdowns in chip investment could pressure the technology business.
Winston Score: 78/100 — Strong
A high-quality business with solid fundamentals.
- Quality: Exceptional (30/30)
- Growth: Exceptional (18/20)
- Cash Flow: Exceptional (9/10)
- Stability: Exceptional (10/10)
- Valuation: Strong (7/10)
- Ownership: Weak (1/15)
Key Facts
Price: $147.70
Market Cap: $49.4B
Sector: Healthcare
Industry: Medical - Instruments & Supplies
Exchange: Other OTC

